To verify the specificity of GPC1, patients with other diseases such as hepatocellular carcinoma, cholangiocarcinoma, gallbladder carcinoma, colorectal carcinoma, gastric carcinoma, and prostate cancer were evaluated. This evidence concerns the gene GPC1 and colorectal carcinoma.